Pharmaceutical contaminants reaching natural aquatic ecosystems can affect fish behaviour, modifying activity patterns, foraging behaviour and antipredator responses. While laboratory-based studies can offer key insights, assessing the ecological relevance of these findings requires field-based approaches. Therefore, we examined the effects of oxazepam, a widely prescribed anxiolytic drug, on the behaviour of a cyprinid fish (the common roach, Rutilus rutilus) in the wild, combining slow-release exposure implants with continuous tracking via acoustic telemetry. To add ecological realism, we created a landscape of fear with an uneven distribution of resources (macrophytes) and exposure to predators (pike, Esox lucius), additionally testing the effects of the drug on roach habitat selection and predator-prey interactions. Fish exposed to the drug showed an increased swimming activity and speed, but exhibited a more constrained spatial distribution in the pond, favouring areas with higher refuge availability. Both exposed and unexposed fish modified their habitat use in the presence of predators. Exposed fish appeared to get closer to the predators when these were caged, but not when predators were free-roaming. Our findings highlight the importance of considering ecological context to understand how pharmaceuticals affect fish behaviour, which is crucial for assessing risks at population and ecosystem levels.

• Klíčová slova
• behaviour, benzodiazepine, fish, home range, oxazepam, predation, telemetry,
• MeSH
• anxiolytika * škodlivé účinky   MeSH
• chemické látky znečišťující vodu * škodlivé účinky   toxicita   MeSH
• chování zvířat * účinky léků   MeSH
• Cyprinidae * fyziologie   MeSH
• ekosystém * MeSH
• oxazepam * škodlivé účinky   MeSH
• predátorské chování účinky léků   MeSH
• zvířata MeSH
• Check Tag
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• anxiolytika * MeSH
• chemické látky znečišťující vodu * MeSH
• oxazepam * MeSH

Pharmaceutical contaminants have spread in natural environments across the globe, endangering biodiversity, ecosystem functioning, and public health. Research on the environmental impacts of pharmaceuticals is growing rapidly, although a majority of studies are still conducted under controlled laboratory conditions. As such, there is an urgent need to understand the impacts of pharmaceutical exposures on wildlife in complex, real-world scenarios. Here, we validate the performance of slow-release pharmaceutical implants-a recently developed tool in field-based ecotoxicology that allows for the controlled chemical dosing of free-roaming aquatic species-in terms of the accumulation and distribution of pharmaceuticals of interest in tissues. Across two years, we directly exposed 256 Atlantic salmon (Salmo salar) smolts to one of four pharmaceutical treatments: clobazam (50 μg g-1 of implant), tramadol (50 μg g-1), clobazam and tramadol (50 μg g-1 of each), and control (0 μg g-1). Fish dosed with slow-release implants containing clobazam or tramadol, or their mixture, accumulated these pharmaceuticals in all of the sampled tissues: brain, liver, and muscle. Concentrations of both pharmaceuticals peaked in all tissues at 1 day post-implantation, before reaching relatively stable, slowly declining concentrations for the remainder of the 30-day sampling period. Generally, the highest concentrations of clobazam and tramadol were detected in the liver, followed by the brain and then muscle, with observed concentrations of each pharmaceutical being higher in the single-exposure treatments relative to the mixture exposure. Taken together, our findings underscore the utility of slow-release implants as a tool in field-based ecotoxicology, which is an urgent research priority given the current lack of knowledge on the real-world impacts of pharmaceuticals on wildlife.

• Publikační typ
• časopisecké články MeSH

Pharmaceutical pollution poses an increasing threat to global wildlife populations. Psychoactive pharmaceutical pollutants (e.g. antidepressants, anxiolytics) are a distinctive concern owing to their ability to act on neural pathways that mediate fitness-related behavioural traits. However, despite increasing research efforts, very little is known about how these drugs might influence the behaviour and survival of species in the wild. Here, we capitalize on the development of novel slow-release pharmaceutical implants and acoustic telemetry tracking tools to reveal that exposure to environmentally relevant concentrations of the benzodiazepine pollutant temazepam alters movement dynamics and decreases the migration success of brown trout (Salmo trutta) smolts in a natural lake system. This effect was potentially owing to temazepam-exposed fish suffering increased predation compared with unexposed conspecifics, particularly at the river-lake confluence. These findings underscore the ability of pharmaceutical pollution to alter key fitness-related behavioural traits under natural conditions, with likely negative impacts on the health and persistence of wildlife populations.

• Klíčová slova
• behaviour, chemical, ecology, global change, survival, telemetry,
• MeSH
• chemické látky znečišťující vodu * toxicita   MeSH
• jezera * MeSH
• migrace zvířat * MeSH
• pstruh * fyziologie   MeSH
• psychotropní léky farmakologie   MeSH
• zvířata MeSH
• Check Tag
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• chemické látky znečišťující vodu * MeSH
• psychotropní léky MeSH

Freshwater ecosystems are under threat from rising pharmaceutical pollution. While such pollutants are known to elicit biological effects on organisms, we have limited knowledge on how these effects might cascade through food-webs, disrupt ecological processes, and shape freshwater communities. In this study, we used a mesocosm experiment to explore how the community impacts of a top-order predator, the eastern mosquitofish (Gambusia holbrooki), are mediated by exposure to environmentally relevant low (measured concentration: ∼10 ng/L) and high concentrations (∼110 ng/L) of the pervasive pharmaceutical pollutant fluoxetine. We found no evidence that exposure to fluoxetine altered the consumptive effects of mosquitofish on zooplankton. However, once mosquitofish were removed from the mesocosms, zooplankton abundance recovered to a greater extent in control mesocosms compared to both low and high fluoxetine-exposed mesocosms. By the end of the experiment, this resulted in fundamental differences in community structure between the control and fluoxetine-treated mesocosms. Specifically, the control mesocosms were characterized by higher zooplankton abundances and lower algal biomass, whereas mesocosms exposed to either low or high concentrations of fluoxetine had lower zooplankton abundances and higher algal biomass. Our results suggest that fluoxetine, even at very low concentrations, can alter aquatic communities and hinder their recovery from disturbances.

• Klíčová slova
• chemical contaminants, fluoxetine, invasive species, pharmaceuticals, primary productivity,
• MeSH
• chemické látky znečišťující vodu * MeSH
• Cyprinodontiformes MeSH
• ekosystém MeSH
• fluoxetin MeSH
• potravní řetězec MeSH
• ryby MeSH
• sladká voda * chemie   MeSH
• zooplankton * účinky léků   MeSH
• zvířata MeSH
• Check Tag
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• chemické látky znečišťující vodu * MeSH
• fluoxetin MeSH